Barbara D. Alexander

Active 1997–2025

106
Papers
20,421
Citations
78
h-index
103
i10-index

Citations

Citations per year for Barbara D. Alexander1990: 1 citations1996: 1 citations1998: 4 citations1999: 4 citations2000: 6 citations2001: 13 citations2002: 4 citations2003: 14 citations2004: 32 citations2005: 60 citations2006: 87 citations2007: 109 citations2008: 110 citations2009: 113 citations2010: 119 citations2011: 170 citations2012: 176 citations2013: 172 citations2014: 192 citations2015: 131 citations2016: 167 citations2017: 164 citations2018: 137 citations2019: 500 citations2020: 551 citations2021: 674 citations2022: 411 citations2023: 369 citations2024: 715 citations2025: 335 citations2026: 2 citations1991–1995: no citations, so these years are not shown1997: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,833 citing papers, 24.7% of this breakdownUnited Kingdom: 449 citing papers, 6% of this breakdownFrance: 412 citing papers, 5.5% of this breakdownGermany: 390 citing papers, 5.3% of this breakdownChina: 365 citing papers, 4.9% of this breakdownSpain: 323 citing papers, 4.4% of this breakdownAustralia: 296 citing papers, 4% of this breakdownItaly: 281 citing papers, 3.8% of this breakdownNetherlands: 263 citing papers, 3.5% of this breakdownCanada: 249 citing papers, 3.4% of this breakdownSwitzerland: 203 citing papers, 2.7% of this breakdownAustria: 189 citing papers, 2.5% of this breakdown
0%24.7%Other 29.3%

Fields

  • Medicine86.6%
  • Biochemistry, Genetics and Molecular Biology5.7%
  • Immunology and Microbiology3.8%
  • Nursing0.9%
  • Agricultural and Biological Sciences0.8%
  • Engineering0.6%
  • Other1.6%

Topics

  • Antifungal resistance and susceptibility20.9%
  • Fungal Infections and Studies15.9%
  • Pneumocystis jirovecii pneumonia detection and treatment3.5%
  • Cytomegalovirus and herpesvirus research3.5%
  • Nail Diseases and Treatments2.9%
  • Plant Pathogens and Fungal Diseases2.4%
  • Other50.9%

Coauthors

All papers

Open in search
  1. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher C. Kibbler, Dimitrios P. Kontoyiannis, Bart Jan Kullberg, Katrien Lagrou, Frédéric Lamoth, Thomas Lehrnbecher, Jürgen Loeffler, Olivier Lortholary, Johan Maertens, Oscar Marchetti, Kieren A. Marr, Henry Masur, Jacques F. Meis, C Orla Morrisey, Márcio Nucci, Luis Ostrosky‐Zeichner, Livio Pagano, Thomas F. Patterson, John R. Perfect, Zdeněk Ráčil, Emmanuel Roilides, Marcus Ruhnke, Cornelia Schaefer Prokop, Shmuel Shoham, Monica A. Slavin, David A. Stevens, George R. Thompson, José A. Vázquez, Claudio Viscoli, Thomas J. Walsh, Adilia Warris, L. Joseph Wheat, P. Lewis White, Theoklis E. Zaoutis, Peter G. Pappas - Clinical Infectious Diseases 2019 cited by 2,817

  2. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Romanee Chaiwarith, Methee Chayakulkeeree, Sharon Chen, Yee‐Chun Chen, Yen‐Hsu Chen, Jun Yong Choi, Young Hwa Choi, Darunee Chotiprasitsakul, Jin-Won Chung, François Danion, Blandine Denis, Emilio Diaz Santos, Miguel O Dictar, Marc Diltoer, Hervé Dupont, Sizhou Feng, Maria Angeles Ferre Colomer, Ricard Ferrer, Jean-Marie Fernand Roger Forel, Jesús Fortün, Julia Garcia‐Diaz, Massimo Girardis, Fang He, Maya Hites, Mao‐Wang Ho, Patrick M. Honoré, Juan Pablo Horcajada, Haihui Huang, Po‐Yen Huang, Yong Huang, Osamah Hussein, Poj Intalapaporn, Sutep Jaruratanasirikul, Luis Jáuregui-Peredo, Misty Johnson, Dong Sik Jung, Kamonwan Jutivorakool, Winfried V. Kern, Daniel H. Kett, Thana Khawcharoenporn, Young Keun Kim, Philipp Koehler, Αναστασία Κοτανίδου, Anne M. Lachiewicz, Qinhan Lin, Luis Eduardo López Cortés, Hong Luo, Roberto Luzzati, ‪Yasmin Maor‬‏, Todd P McCarty, Maria Merelli, Paloma Merino Amador, John Midturi, Guglielmo Marco Migliorino, Jean‐Paul Mira, Piroon Mootsikapun, Orla Morrissey, Patricia Muñoz García de Paredes, Cristina Mussini, Eleftherios Mylonakis, Saadalla Nseir, William Nseir, Zekaver Odabaşı, Vasileios Papastamopoulos, David L. Paterson, Thomas F. Patterson, Kyong Ran Peck, Zhiyong Peng, Nitipong Permpalung, Gaëtan Plantefève and 42 more - The Lancet 2022 cited by 168

  3. Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial

    Authors: , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2021 cited by 300

  4. Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2010 cited by 1,552

  5. C5a-licensed phagocytes drive sterilizing immunity during systemic fungal infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail S. Lionakis - Cell 2023 cited by 104

  6. Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2010 cited by 1,442

  7. Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

    Authors: , , , , , , , , , - Clinical Infectious Diseases 2013 cited by 776

  8. A conceptual framework for nomenclatural stability and validity of medically important fungi: a proposed global consensus guideline for fungal name changes supported by ABP, ASM, CLSI, ECMM, ESCMID-EFISG, EUCAST-AFST, FDLC, IDSA, ISHAM, MMSA, and MSGERC

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kristie Johnson, Julianne V. Kus, Ruoyu Li, Jacques F. Meis, Michaela Lackner, Fanny Lanternier, Sixto M. Leal, Francesca Lee, Shawn R. Lockhart, Paul M. Luethy, Isabella W. Martin, Kyung J. Kwon‐Chung, Wieland Meyer, M. Hong Nguyen, Luis Ostrosky‐Zeichner, Elizabeth Palavecino, Preeti Pancholi, Peter G. Pappas, Gary W. Procop, Scott A. Redhead, Daniel D. Rhoads, Stefan Riedel, Bryan S. Stevens, Kaede Ota Sullivan, Paschalis Vergidis, Emmanuel Roilides, Amir Seyedmousavi, Lili Tao, Vânia Aparecida Vicente, Roxana G. Vitale, Qiming Wang, Nancy L. Wengenack, Lars F. Westblade, Nathan P. Wiederhold, Lewis White, Christina Wojewoda, Sean X. Zhang - Journal of Clinical Microbiology 2023 cited by 61

  9. Invasive Non- Aspergillus Mold Infections in Transplant Recipients, United States, 2001–2006

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Emerging infectious diseases 2011 cited by 319

  10. Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections

    Authors: , , , , , , , , , - Journal of Fungi 2022 cited by 48

  11. Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance

    Authors: , , , , , , , , , , , , - Nature Communications 2016 cited by 275

  12. MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nikolaos G. Almyroudis, David R. Andes, Susan Hadley, Michelle Barron, Katheen Mullane, Loren G. Miller - Journal of Antimicrobial Chemotherapy 2019 cited by 86

  13. Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC/MSGERC

    Authors: , , , , , , - Clinical Infectious Diseases 2020 cited by 127

  14. CX3CR1-dependent renal macrophage survival promotes Candida control and host survival

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2013 cited by 225

  15. Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients

    Authors: , , , , , , , , - American Journal of Transplantation 2004 cited by 884

  16. Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis

    Authors: , , , - Clinical Infectious Diseases 2017 cited by 150

  17. Pharmacodynamics of Oral Ganciclovir and Valganciclovir in Solid Organ Transplant Recipients

    Authors: , , , , , , , , , , - Transplantation 2005 cited by 201

  18. The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)

    Authors: , , , , , , , , , , , , , , , , , - Transplant Infectious Disease 2016 cited by 176

  19. Antifungal Activities of SCY-078 (MK-3118) and Standard Antifungal Agents against Clinical Non-Aspergillus Mold Isolates

    Authors: , - Antimicrobial Agents and Chemotherapy 2015 cited by 98

  20. Bronchopulmonary Dysplasia and Perinatal Characteristics Predict 1-Year Respiratory Outcomes in Newborns Born at Extremely Low Gestational Age: A Prospective Cohort Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gautam K. Singh, Barbara Warner, Philip L. Ballard, Roberta A. Ballard, David J. Durand, Eric C. Eichenwald, Amir Khan, Leslie Lusk, Jeffrey D. Merrill, Dennis W. Nielson, Jeanette Asselin, Samantha Balan, Katrina Burson, Cheryl Chapin, Erna Josiah-Davis, Carmen Garcia, Hart Horneman, Rick Hinojosa, Christopher N. Johnson, Susan Kelley, Karin L. Knowles, M. Layne Lillie, Karen Martin, Sarah K. Martin, Julie Arldt-McAlister, Georgia E. McDavid, Lori Pacello, Shawna Rodgers, Daniel K. Sperry, Judy L. Aschner, Amy B. Beller, Candice D. Fike, Scott O. Guthrie, Tina V. Hartert, Nathalie L. Maitre, Mark O'Hunt, Theresa J. Rogers, Odessa L. Settles, Steven Steele, Marshall Summar, Sharon Wadley, Carl T. D’Angio, Vasanth Kumar, T.J. Mariani, Gloria Pryhuber, Clement L. Ren, Anne Marie Reynolds, Rita M. Ryan, Kristin Scheible, Heidie Huyck, Valerie Lunger, Shannon Castiglione, Aimee Horan, Deanna Maffet, Jane O’Donnell, Michael Sacilowski, Tanya Scalise, Elizabeth Werner, Jason Zayac, Kim Bordeaux, Pam Brown, Julia Epping, Lisa Flattery-Walsh, Donna Germuga, Nancy Piper Jenks, Mary Jane Platt, Eileen Popplewell, Sandra Prentice, Kim Ciccio, C. Michael Cotten and 16 more - The Journal of Pediatrics 2017 cited by 203

  21. Infections Due to Scedosporium apiospermum and Scedosporium prolificans in Transplant Recipients: Clinical Characteristics and Impact of Antifungal Agent Therapy on Outcome

    Authors: , , , , , , , - Clinical Infectious Diseases 2004 cited by 399

  22. Molecular Identification of Aspergillus Species Collected for the Transplant-Associated Infection Surveillance Network

    Authors: , , , , , , , , , , , , - Journal of Clinical Microbiology 2009 cited by 300

  23. The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: Executive summary

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Heart and Lung Transplantation 2016 cited by 196

  24. Hospital and neurodevelopmental outcomes of extremely low-birth-weight infants with necrotizing enterocolitis and spontaneous intestinal perforation

    Authors: , , , , , , , , - Journal of Perinatology 2011 cited by 144